continuous treatment

BEHAVIORAL2 trials

Sponsors

Shanghai Zhongshan Hospital, Henan Provincial People's Hospital

Conditions

Ankylosing SpondylitisChronic Hepatitis BTherapeutic Agent Toxicity

Unknown Phase

A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

Shanghai Zhongshan HospitalAnkylosing Spondylitis, Therapeutic Agent Toxicity

Start: 2020-05-07End: 2022-06-30Target: 196Updated: 2020-05-27

Study on Clinical Program Optimization of Inactive Hepatitis B Surface Antigen (HBsAg) Carriers (IHCs)

Henan Provincial People's HospitalChronic Hepatitis B

Start: 2021-10-01End: 2024-09-30Target: 80Updated: 2022-07-14